Figure 3
Mammary gland cell populations analysed from mammary gland secretions for the 1.2 mg dose of inclusion bodies containing active (MMP-9 IBs) or inactive (mutMMP-9 IBs) matrix metalloproteinase-9 and control, along 0, 1, 3, 6, and 9 days-post infusion. All cell measurements are expressed in million (106) cells per mL (M cells/ml). Non-transformed means and SEM (error bars) are represented while P-values were obtained from transformed data, when necessary. Asterisks depict significant differences between treatments and the control group within time. (a) Somatic cell counts (SCC); P < 0.0001. (b) White blood cells (WBC); P < 0.0001. at P = 0.053. (c) Mononuclear cells (MNC); P < 0.0001. (d) Polymorphonuclear cells (PMNC); P < 0.0001. For differences between different treatments within each time point, see Table S3 in the Supplementary Material.
